Paul, Weiss, Rifkind, wharton & Garrison LLP


Recent News About Paul, Weiss, Rifkind, wharton & Garrison LLP View More

Judge: Settlement talks begun in mass action vs Abbvie, others over Androgel, testosterone drugs

By Jonathan Bilyk | Sep 10, 2018

A federal judge has put a hold on any further proceedings in the massive, years-long nationwide legal action against Abbvie and other makers of so-called testosterone replacement therapy drugs, saying he wants to give both sides time to complete a potential settlement drug to permanently end the litigation.

Chase to pay $19M to settle black financial advisors' suit alleging denied opportunities; lawyers to claim $5.5M

By Dan Churney | Sep 7, 2018

JP Morgan Chase Bank has agreed to pay more than $19.5 million to settle a class action suit brought in Chicago federal court by several of its employees, who alleged the banking giant assigned its black and African-American financial advisors to less profitable locations and denied them other opportunities to get ahead, because of their race.

Drug maker AbbVie wants to slip from $140M verdict, says jury ignored evidence

By Dan Churney | Nov 6, 2017

North Chicago-based drug company AbbVie is urging a federal judge to trash a verdict ordering it to cough up $140 million, because its testosterone therapy drug AndroGel contributed to a man's heart attack, contending it has no liability because AndroGel was approved by the FDA.

The Record Network